STOCK TITAN

[Form 4] Amrize Ltd Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Ian A. Johnston, identified as Chief Financial Officer, executed multiple purchases totaling 10,500 ordinary shares of Amrize Ltd on 08/08/2025 at prices between $47.66 and $47.75 per share. The reported transactions raised his beneficial ownership to 17,344 ordinary shares. The Form 4 lists only non-derivative purchases in separate lots and shows no derivative holdings reported.

Ian A. Johnston, identificato come Chief Financial Officer, ha eseguito più acquisti per un totale di 10,500 azioni ordinarie di Amrize Ltd l'08/08/2025 a prezzi compresi tra $47.66 e $47.75 per azione. Le transazioni riportate hanno portato la sua titolarità beneficiaria a 17,344 azioni ordinarie. Il Modulo 4 elenca solo acquisti non derivati in lotti separati e non mostra detenzioni di strumenti derivati.

Ian A. Johnston, identificado como Chief Financial Officer, realizó varias compras por un total de 10,500 acciones ordinarias de Amrize Ltd el 08/08/2025 a precios entre $47.66 y $47.75 por acción. Las transacciones notificadas elevaron su titularidad beneficiaria a 17,344 acciones ordinarias. El Formulario 4 solo registra compras no derivadas en lotes separados y no muestra posiciones en derivados.

Ian A. Johnston은 최고재무책임자(CFO)로 기재되어 있으며, 08/08/2025에 Amrize Ltd의 보통주 10,500주를 총합으로 매수했고 주당 $47.66에서 $47.75 사이의 가격대에서 여러 차례 거래를 실행했습니다. 보고된 거래로 그의 수익적 소유권은 17,344 보통주로 증가했습니다. Form 4 서식에는 별도 거래로 이루어진 비파생상품(현물) 매수만 기재되어 있으며 파생상품 보유는 보고되어 있지 않습니다.

Ian A. Johnston, désigné Chief Financial Officer, a effectué plusieurs achats totalisant 10,500 actions ordinaires d'Amrize Ltd le 08/08/2025 à des prix compris entre $47.66 et $47.75 par action. Ces opérations ont porté sa propriété bénéficiaire à 17,344 actions ordinaires. Le formulaire 4 n'indique que des achats non dérivés en lots séparés et ne signale aucune détention de dérivés.

Ian A. Johnston, als Chief Financial Officer geführt, führte am 08.08.2025 mehrere Käufe von insgesamt 10,500 Stammaktien der Amrize Ltd zu Preisen zwischen $47.66 und $47.75 pro Aktie durch. Durch die gemeldeten Transaktionen erhöhte sich sein wirtschaftliches Eigentum auf 17,344 Stammaktien. Das Formular 4 führt lediglich nicht-derivative Käufe in separaten Tranchen auf und weist keine Derivatpositionen aus.

Positive
  • Insider purchases totaling 10,500 ordinary shares at prices between $47.66 and $47.75
  • Reported beneficial ownership increased to 17,344 ordinary shares, showing higher insider stake
Negative
  • None.

Insights

TL;DR: Multiple insider buys totaling 10,500 shares at about $47.7 raise the CFO's stake to 17,344, a signaling event but not clearly material alone.

The transaction record documents a series of purchases executed on 08/08/2025, with per-share prices ranging $47.66–$47.75. Aggregate insider purchases of 10,500 shares can be interpreted as a positive disclosure signal from management; however, without company market-cap or outstanding share count in this filing, the absolute materiality for investors is unclear. No options, warrants, or other derivative instruments were reported.

TL;DR: Form 4 shows compliant, itemized reporting of multiple ordinary-share purchases by the CFO; disclosure appears complete for non-derivative activity.

The filing provides line-item detail for each lot purchased and the cumulative beneficial ownership following the trades. The report identifies the reporting person as Chief Financial Officer and documents only purchases of ordinary shares. From a governance and disclosure perspective, the Form 4 fulfills Section 16 reporting of insider acquisitions; there are no amendments, derivative positions, or denial-of-filing indicators present in the text provided.

Ian A. Johnston, identificato come Chief Financial Officer, ha eseguito più acquisti per un totale di 10,500 azioni ordinarie di Amrize Ltd l'08/08/2025 a prezzi compresi tra $47.66 e $47.75 per azione. Le transazioni riportate hanno portato la sua titolarità beneficiaria a 17,344 azioni ordinarie. Il Modulo 4 elenca solo acquisti non derivati in lotti separati e non mostra detenzioni di strumenti derivati.

Ian A. Johnston, identificado como Chief Financial Officer, realizó varias compras por un total de 10,500 acciones ordinarias de Amrize Ltd el 08/08/2025 a precios entre $47.66 y $47.75 por acción. Las transacciones notificadas elevaron su titularidad beneficiaria a 17,344 acciones ordinarias. El Formulario 4 solo registra compras no derivadas en lotes separados y no muestra posiciones en derivados.

Ian A. Johnston은 최고재무책임자(CFO)로 기재되어 있으며, 08/08/2025에 Amrize Ltd의 보통주 10,500주를 총합으로 매수했고 주당 $47.66에서 $47.75 사이의 가격대에서 여러 차례 거래를 실행했습니다. 보고된 거래로 그의 수익적 소유권은 17,344 보통주로 증가했습니다. Form 4 서식에는 별도 거래로 이루어진 비파생상품(현물) 매수만 기재되어 있으며 파생상품 보유는 보고되어 있지 않습니다.

Ian A. Johnston, désigné Chief Financial Officer, a effectué plusieurs achats totalisant 10,500 actions ordinaires d'Amrize Ltd le 08/08/2025 à des prix compris entre $47.66 et $47.75 par action. Ces opérations ont porté sa propriété bénéficiaire à 17,344 actions ordinaires. Le formulaire 4 n'indique que des achats non dérivés en lots séparés et ne signale aucune détention de dérivés.

Ian A. Johnston, als Chief Financial Officer geführt, führte am 08.08.2025 mehrere Käufe von insgesamt 10,500 Stammaktien der Amrize Ltd zu Preisen zwischen $47.66 und $47.75 pro Aktie durch. Durch die gemeldeten Transaktionen erhöhte sich sein wirtschaftliches Eigentum auf 17,344 Stammaktien. Das Formular 4 führt lediglich nicht-derivative Käufe in separaten Tranchen auf und weist keine Derivatpositionen aus.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Johnston Ian A

(Last) (First) (Middle)
GRAFENAUWEG 8

(Street)
ZUG V8 6300

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Amrize Ltd [ AMRZ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 08/08/2025 P 5,370 A $47.73 12,214 D
Ordinary Shares 08/08/2025 P 1,459 A $47.68 13,673 D
Ordinary Shares 08/08/2025 P 1,041 A $47.67 14,714 D
Ordinary Shares 08/08/2025 P 750 A $47.71 15,464 D
Ordinary Shares 08/08/2025 P 575 A $47.69 16,039 D
Ordinary Shares 08/08/2025 P 500 A $47.74 16,539 D
Ordinary Shares 08/08/2025 P 300 A $47.72 16,839 D
Ordinary Shares 08/08/2025 P 150 A $47.7 16,989 D
Ordinary Shares 08/08/2025 P 111 A $47.73 17,100 D
Ordinary Shares 08/08/2025 P 100 A $47.715 17,200 D
Ordinary Shares 08/08/2025 P 100 A $47.75 17,300 D
Ordinary Shares 08/08/2025 P 44 A $47.66 17,344 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Hans Weinburger, Attorney-in-Fact 08/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who reported the trades for Amrize (AMRZ)?

Ian A. Johnston, identified in the filing as the company's Chief Financial Officer, is the reporting person.

How many shares did the Amrize (AMRZ) insider buy?

10,500 ordinary shares were purchased in multiple lots as reported in the Form 4.

At what prices were the Amrize (AMRZ) shares purchased?

The reported lot prices range from $47.66 to $47.75 per share.

What is the reporting person’s total beneficial ownership after these transactions?

17,344 ordinary shares beneficially owned following the reported purchases.

Were any derivative securities reported in the Amrize (AMRZ) Form 4?

No derivative securities (options, warrants, convertible instruments) are listed in the provided Table II.
Amrize Ltd

NYSE:AMRZ

AMRZ Rankings

AMRZ Latest News

AMRZ Latest SEC Filings

AMRZ Stock Data

27.64B
506.75M
7%
19.44%
0.45%
Building Materials
Cement, Hydraulic
Link
Switzerland
ZUG